Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors have?
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors has 5,556 citations in the OpenAlex counts ScholarIQ stores.
When was Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors published?
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors has 2017 year in the ScholarIQ index.
What is the open-access status of Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors?
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors has closed oa status in the ScholarIQ index.
What is the DOI of Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors?
The DOI for Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors is on the source record.
What is the PMID of Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors?
The PMID for Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors is on the source record.
What is the OpenAlex record for Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors?
The OpenAlex for Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors is on the source record.